spectra revealed the attachments of these two methylene
carbons with protons resonated at δ 2.61 (m, overlapped).
Furthermore, HMBC correlations (Figure 1) between
H-200 and C-100 and between H-300 and C-400 confirmed
the existence of SA moiety in the molecule. Moreover,
these four distinct units were connected with the help
unit showed a correlation with a carbon signal at δ 174.1
(C-100) of SA unit. Thus, the structure of ieodoglucomide
B (2) was determined and the overall assignments of
1H and 13C NMR data were unambiguously made on
1
1
the basis of the Hꢀ H COSY, ROESY, HSQC, and
HMBC spectra.
Figure 3. ΔδH values (ΔδH = δS ꢀ δR) obtained for (S)- and
(R)-MTPA esters of HMA of 1.
The absolute stereochemistry of amino acid (AA), C-14
of HMA, and Glu moiety in 1 and 2 was determined by
Marfey’s method,12 Mosher’s method,13,14 and compar-
isons of optical rotation and Rf value with an authentic
sample, respectively. After acid hydrolysis, the reaction
mixtures were extracted with n-Hexane, ethyl acetate and
methanol to obtain HMA, AA, and Glu moiety respec-
tively. Ala of 1 was found to be of the L form. The absolute
configuration of the stereocenter at C-14 of HMA unit in 1
and 2 was determined by treating HMA with (R)-(ꢀ)- and
(S)-(þ)-R-methoxy-R-(trifluoromethyl)phenylacetyl chlo-
ride (MTPA-Cl) in dry pyridine separately to yield (S)- and
(R)- MTPA ester derivatives 1a, 1b, 2a, and 2b, respectively
(Figure 3 and Supporting Information). All proton signals
Figure 2. Acid hydrolysis of 1.
of HMBC and ROSEY correlations. The connectivity
between HMA and NH of Ala group was confirmed by
the ROESY and HMBC correlations between NH proton
and H-2 and C-1 of HMA unit, respectively. The oxyge-
nated proton at δ 3.42 (H-14) of HMA unit showed an
HMBC correlation with the anomeric carbon of Glu at δ
104.2 (C-1000). On the other hand, methylene proton signals
at δ 4.18 (H-6a000) and 4.44 (H-6b000) of Glu unit correlated
with a carbon signal at δ 174.0 (C-100) of SA unit. From
these detailed NMR data analyses, the planar structure of
ieodoglucomide A (1) was unambiguously determined.
Ieodoglucomide B (2) was also isolated as a yellowish oil
similar to 1, and its molecular formula was assigned to be
C29H51NO12 with the aid of HRESI-MS [M ꢀ H]ꢀ at
m/z 604.3339 (calcd 605.3411 for C29H51NO12) and 1H and
13C NMR analysis (Table 1). The IR spectrum showed
absorption bands for hydroxyl (3349 cmꢀ1) and amide
carbonyl (1660 cmꢀ1) groups. The NMR results were
found to be essentially identical to those of 1 which con-
firmed that 2 also contained HMA, SA and Glu moiety.
The only difference was the observation of glycine (Gly)
instead of Ala which was also confirmed by the absence of
1H and 13C signals of methyl group and the existence of an
amide proton at δ 8.02 and a methylene proton as singlet at
δ 3.89 (H-20). The ROESY and HMBC data in DMSO-d6
indicated the correlations between NH proton of Gly with
H-2 and C-1 of HMA unit and with methine proton of Gly
at δ 3.89 (H-20). The oxygenated proton at δ 3.43 (H-14) of
HMA unit showed an HMBC correlation with the anome-
ric carbon of Glu at δ 104.2 (C-1000). Furthermore, methy-
lene protons at δ 4.17 (H-6a000) and 4.44 (H-6b000) of Glu
1
of the derivatives were assigned by 1Hꢀ H COSY experi-
1
ment and H NMR chemical shifts (ΔδH = δS ꢀ δR).
These data allowed the assignment of the absolute config-
uration of C-14 of 1 and 2 as S (Figure 3). The absolute
configuration of the Glu moiety for both compounds was
determined to be the β-D-form by comparing the signof the
optical rotation [0.6 mg, [R]23D þ27 (c 0.14, H2O)] and Rf
value (0.58) with an authentic sample.
Ieodoglucomides A and B were found to have moderate
antimicrobial activity when tested against both Gram-
positive and Gram-negative bacteria and fungi following
broth dilution assay technique (Table 2).15 Different
growth conditions of bacteria and fungi were maintained
while culturing these microorganisms.16,17
The cytotoxicity of 1 and 2 was evaluated against six
human cancer cell lines (breast cancer: MDA-MB-231,
colon cancer: HCT15, prostate cancer: PC-3, lung cancer:
NCI-H23, stomach cancer: NUGC-3, and renal cancer:
(12) Marfey, P. Carlsberg Res. Commun. 1984, 49, 591–596.
(13) Ohtani, I.; Kusumi, T.; Kashman, Y.; Kakisawa, H. J. Am.
Chem. Soc. 1991, 113, 4092–4096.
(14) Tsuda, M.; Toriyabe, Y.; Endo, T.; Kobayashi, J. Chem. Pharm.
Bull. 2003, 51, 448–451.
(15) Appendio, G.; Gibbons, S.; Giana, A.; Pagani, A.; Grassi, G.;
Stavri, M.; Smith, E.; Rahman, M. M. J. Nat. Prod. 2008, 71, 1427–1430.
(16) Oluwatuyi, M.; Kaatz, G. W.; Gibbons, S. Phytochemistry 2004,
65, 3249–3254.
(17) Yu, J. Q.; Lei, J. C.; Yu, H. D.; Cai, X.; Zou, G. L. Phytochem-
istry 2004, 65, 881–884.
1466
Org. Lett., Vol. 14, No. 6, 2012